Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06641297 · ClinicalTrials.gov registry record · NA

White Matter Plasticity in Schizophrenia

A NA study of Schizophrenia Disorders, sponsored by University of Maryland, Baltimore.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
2
Study locations

NCT06641297 is a NA study of Schizophrenia Disorders that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 36 participants, below the 133-participant average among 5 other Schizophrenia Disorders trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06641297, a NA study of Schizophrenia Disorders, is actively recruiting participants, sponsored by University of Maryland, Baltimore.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
2
Study locations

Study Summary

Schizophrenia spectrum disorders are associated with impairment in the microstructure of white matter, the key brain tissue responsible for fast communication between different brain regions necessary for any complex task. This white matter impairment is linked to problems with cognition in schizophrenia, especially slower processing speed. This project aims to study the potential for correcting white matter deficits in schizophrenia by examining mechanisms underlying white matter structure changes in response to training on playing a mock musical instrument.

Conditions Studied

Interventions

  • BEHAVIORAL Music video game

Study Locations (2)

Maryland

  • Maryland Psychiatric Research Center - Catonsville
  • University of Maryland Baltimore - Maryland Psychiatric Research Center - Catonsville

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2025-01-02
Est. Completion 2026-12-31
Phase NA

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT06641297

The ClinicalTrials.gov registry entry for NCT06641297 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 133-participant average among 5 other Schizophrenia Disorders trials with a reported enrollment target (73% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia Disorders appearing as the primary indexed condition, and to 1 intervention - of which Music video game is the first listed.

NCT06641297 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06641297 about?

NCT06641297 is a clinical study titled "White Matter Plasticity in Schizophrenia". Schizophrenia spectrum disorders are associated with impairment in the microstructure of white matter, the key brain tissue responsible for fast communication between different brain regions necessary for any complex task. This white matter impairment is linked to problems with cognition in schizoph...

What is the current status of trial NCT06641297?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-01-02. Estimated completion is 2026-12-31.

What conditions does trial NCT06641297 study?

This clinical trial studies the following conditions: Schizophrenia Disorders.

What interventions are being tested in trial NCT06641297?

The interventions under investigation include: Music video game (BEHAVIORAL).

Who is sponsoring clinical trial NCT06641297?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06641297 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.